Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Current Assets (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Current Assets came in at $59.8 billion in Q2 2026, up 9.68% year-over-year from $54.5 billion in Q2 2025, and up 1.02% quarter-over-quarter from $59.2 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Current Assets (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Current Assets across 18 years of filings, most recently posting $59.8 billion for Q2 2026.

  • In Q2 2026, Current Assets rose 9.68% year-over-year to $59.8 billion; the TTM figure through Jun 2026 stood at $59.8 billion (up 9.68% YoY), while the FY2025 annual figure was $55.6 billion, changed 0.48% from the prior year.
  • Current Assets came in at $59.8 billion for Q2 2026 at Johnson & Johnson, up from $59.2 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $71.6 billion in Q1 2025 to a low of $53.2 billion in Q3 2024.
  • Average Current Assets over 5 years is $58.8 billion, with a median of $57.8 billion recorded in 2024.
  • Year-over-year, Current Assets declined 17.68% in 2023 and advanced 25.52% in 2025.
  • Over 5 years, Current Assets stood at $65.2 billion in 2022, then fell by 18.0% to $53.5 billion in 2023, then increased by 4.48% to $55.9 billion in 2024, then fell by 0.48% to $55.6 billion in 2025, then gained by 7.46% to $59.8 billion in 2026.
  • Per Business Quant data, the three most recent Current Assets figures were $59.8 billion in Q2 2026, $59.2 billion in Q1 2026, and $55.6 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 59.77 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 33.67 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 27.35 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 41.36 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 36.64 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - 4.03 Bn
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 6.03 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 3.48 Bn
10 Jazz Pharmaceuticals 16.02 Bn 14.40 Bn 1.09 Bn 3.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 59.77 Bn
Mar 29, 2026 59.17 Bn
Dec 28, 2025 55.62 Bn
Sep 28, 2025 54.61 Bn
Jun 29, 2025 54.50 Bn
Mar 30, 2025 71.55 Bn
Dec 29, 2024 55.89 Bn
Sep 29, 2024 53.25 Bn
Jun 30, 2024 57.82 Bn
Mar 31, 2024 57.00 Bn
Dec 31, 2023 53.50 Bn
Oct 1, 2023 53.70 Bn
Jul 2, 2023 60.57 Bn
Apr 2, 2023 64.39 Bn
Jan 1, 2023 55.29 Bn
Oct 2, 2022 65.24 Bn
Jul 3, 2022 63.85 Bn
Apr 3, 2022 60.42 Bn
Jan 2, 2022 60.98 Bn
Oct 3, 2021 59.89 Bn